VAERS reports by lot

Seqirus / CSL Flu lot 195239: VAERS reports

21 VAERS reports list lot 195239 as a Seqirus / CSL Flu vaccine, received between 2017-10-18 and 2019-01-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
5%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2323%
Neurological2020%
Cardiac / Cardiovascular1818%
Injection-site / Local reaction1515%
Musculoskeletal1010%
Allergic / Anaphylactic77%
Dermatological (non-injection-site)33%
Respiratory22%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 11).

Florida3
Tennessee2
North Carolina2
Illinois2
New York1
Idaho1
Alabama1
Virginia1
Georgia1
Colorado1
Michigan1

Reports by month received

2017-103
2017-113
2018-0111
2018-022
2018-091
2019-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.